Ciba Specialty Chemicals to partner with Biosignal Ltd for antibiofilm products
Novel antibiofilm technology mimics natural defenses seen in seaweed
Ciba specialty chemicals announced the completion of a joint development and licensing agreement with Biosignal, Sydney, Australia to develop novel antimicrobial compounds for consumer and industrial products based upon Biosignal's antibiofilm technology. Biosignal has granted Ciba Specialty Chemicals an exclusive license in some of Ciba's key markets including plastics, coatings, paints, fibres and paper products.
The formation of biofilms in many industrial environments can lead to fouling, corrosion, material degradation and general contamination. Biosignal's antibiofilm technology is based on a discovery that the eastern Australian seaweed Delisea pulchra produces natural furanones that disable bacteria's ability to colonize.
Development is expected to begin next month and testing will occur at Ciba's laboratories in Basel, Switzerland and at Biosignal's laboratories in Sydney, Australia.
Other news from the department business & finance
These products might interest you
Gilson MyPIPETMAN Select and MyPIPETMAN Enterprise Pipettes by Gilson
Grab the Gilson pipettes with your name and favorite colors!
Customise Your Pipettes to Fit Your Research
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
